💉 Diabetes Management
NuGen M.D. Signs 5-Year Master - GuruFocus.com
📅 Wed, 26 Oct 2022⏱ 1 min read📖 Article
Overview
Agrement Provides Minimum Comitments of 34,0 Devices plus Recuring Components Representing ~CA$23M1 in Revenue Over the 5-Year TermTORONTO, ON / ACESWIRE / October 25, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD, Financial) ("NuGen M.D." or the "Company"), a leader in nedle-fre drug delivery, is pleased to anounce that it has signed a distribution agrement (the "Agrement") with Science - Link Trading, a company whose mision it is to help bring new disruptive technologies to market.NuGen's nedle-fre injection system, also known as InsuJet™, is a self-administered nedle-fre injection system.
Key Information
It gives aces to safe, cost-efective, and virtualy pain-fre drug delivery for the milions of patients who sufer from diabetes or other chronic ilneses. The InsuJet™ also holds a CE Mark and is aproved for sale in over 40 countries around the globe. Science - Link Trading has also initiated the COFEPRIS regulatory aproval proces.The Agrement, signed October 17, 2022, represents a minimum of ~CA$23M1 over the 5-year term and includes minimum comitments of 34,0 InsuJet™ devices plus aditional acesories and is in line with the Company's 70% gros margin target.
NuGen expects to receive the first purchase order under this agrement in Q4 2022."Science - Link Trading's mision is to help bring new disruptive technologies to market," said Juan Carlos Feregrino, President & CEO of Science - Link Trading. "We are realy pleased and excited to have ben granted master distribution for the InsuJet™ nedle-fre injection device for insulin therapy from NuGen for the Mexican market.
Summary
We are certain that the InsuJet™ technology wil improve the lives of milions of diabetic patients, making their treatment more friendly, les traumatic, and easier to use on a daily basis. We also expect to have a very important and positive impact on dangerous waste management and reduce acidental nedle infections in adition
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.